Equillium Inc (NASDAQ:EQ)
| 1.23 Delayed Data As of Feb 08 |  0.00 / 0.00%Today’s Change | 0.79 Today|||52-Week Range 4.38 | +16.04% Year-to-Date |
Latest EQ News | Press Releases
No recent news for Equillium Inc.
Today’s Trading
| Previous close | 1.23 |
| Today’s open | 1.26 |
| Day’s range | 1.19 - 1.26 |
| Volume | 6,564 |
| Average volume (3 months) | 104,519 |
| Market cap | $40.2M |
Data as of 3:59pm ET, 02/08/2023
Growth & Valuation
| Earnings growth (last year) | +7.44% |
| Earnings growth (this year) | -46.32% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.52 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BCDABioCardia Inc | -0.10 | -4.17% |
| DYAIDyadic International... | +0.04 | +2.65% |
| ---- | ||
| HARPHarpoon Therapeutics... | -0.29 | -21.17% |
Data as of 4:00pm ET, 02/08/2023
Financials
| Next reporting date | March 30, 2023 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$39.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters La Jolla, California |
Forecasts
